Ingevity Corporation (NYSE:NGVT) Given Average Rating of “Hold” by Brokerages

Shares of Ingevity Corporation (NYSE:NGVT) have received a consensus rating of “Hold” from the five analysts that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and two have issued a buy recommendation on the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $80.00.

Several equities research analysts have issued reports on NGVT shares. Weiss Ratings reiterated a “sell (d-)” rating on shares of Ingevity in a research note on Tuesday, April 21st. BMO Capital Markets reiterated an “outperform” rating and set a $83.00 price objective on shares of Ingevity in a research note on Monday, March 2nd. Wells Fargo & Company increased their price objective on shares of Ingevity from $65.00 to $75.00 and gave the company an “equal weight” rating in a research note on Friday, February 27th. Jefferies Financial Group reiterated a “buy” rating and set a $82.00 price objective on shares of Ingevity in a research note on Thursday, February 26th. Finally, Wall Street Zen downgraded shares of Ingevity from a “strong-buy” rating to a “buy” rating in a research note on Saturday.

Ingevity Price Performance

NGVT opened at $72.18 on Friday. The company has a quick ratio of 0.92, a current ratio of 1.42 and a debt-to-equity ratio of 27.83. Ingevity has a 52-week low of $39.74 and a 52-week high of $79.29. The company has a 50 day moving average of $71.39 and a two-hundred day moving average of $67.08. The company has a market cap of $2.51 billion, a P/E ratio of -20.33 and a beta of 1.18.

Ingevity (NYSE:NGVT) last released its quarterly earnings data on Wednesday, May 6th. The company reported $1.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.84 by $0.31. Ingevity had a negative net margin of 10.55% and a positive return on equity of 207.82%. The company had revenue of $258.00 million during the quarter, compared to the consensus estimate of $254.73 million. During the same period in the previous year, the firm earned $1.01 earnings per share. Ingevity’s revenue for the quarter was up 4.1% on a year-over-year basis. Ingevity has set its FY 2026 guidance at 4.700-5.200 EPS. On average, analysts expect that Ingevity will post 5.05 earnings per share for the current year.

Insider Buying and Selling at Ingevity

In other Ingevity news, SVP Terrance M. Dyer sold 496 shares of the stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $68.49, for a total transaction of $33,971.04. Following the sale, the senior vice president directly owned 7,202 shares of the company’s stock, valued at approximately $493,264.98. This represents a 6.44% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.88% of the company’s stock.

Institutional Trading of Ingevity

A number of institutional investors and hedge funds have recently modified their holdings of NGVT. Global Retirement Partners LLC acquired a new stake in shares of Ingevity during the fourth quarter worth $27,000. Meeder Asset Management Inc. acquired a new stake in shares of Ingevity during the fourth quarter worth $33,000. Geneos Wealth Management Inc. raised its holdings in shares of Ingevity by 85.8% during the second quarter. Geneos Wealth Management Inc. now owns 838 shares of the company’s stock worth $36,000 after purchasing an additional 387 shares during the period. Headlands Technologies LLC acquired a new stake in shares of Ingevity during the second quarter worth $46,000. Finally, Kestra Advisory Services LLC acquired a new stake in shares of Ingevity during the fourth quarter worth $47,000. 91.59% of the stock is owned by institutional investors and hedge funds.

About Ingevity

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.